{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:44:11Z","timestamp":1775123051309,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Connective Tissue Diseases Research Center, Tabriz"},{"name":"University of Medical Sciences, Tabriz, Iran"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.imlet.2018.11.005","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T16:55:26Z","timestamp":1542214526000},"page":"120-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Interleukin-33 gene expression and rs1342326 polymorphism in Beh\u00e7et\u2019s disease"],"prefix":"10.1016","volume":"212","author":[{"given":"Mahsa","family":"Talei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariush","family":"Shanebandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Jadidi-Niaragh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Khabazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Babaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahriar","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Afkari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahim","family":"Sakhinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohreh","family":"Babaloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.imlet.2018.11.005_bib0005","first-page":"1384","article-title":"WHO-ILAR COPCORD study (Stage 1, urban study) in Iran","volume":"35","author":"Davatchi","year":"2008","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.imlet.2018.11.005_bib0010","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1136\/bjo.2007.124875","article-title":"Behcet\u2019s disease: global epidemiology of an Old Silk Road disease","volume":"91","author":"Keino","year":"2007","journal-title":"Br. J. Ophthalmol."},{"issue":"10","key":"10.1016\/j.imlet.2018.11.005_bib0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","article-title":"New insights into the pathogenesis of Behcet\u2019s disease","volume":"11","author":"Pineton de Chambrun","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"3-4","key":"10.1016\/j.imlet.2018.11.005_bib0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","article-title":"Behcet\u2019s disease--a contemporary review","volume":"32","author":"Mendes","year":"2009","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.imlet.2018.11.005_bib0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/1756-185X.12153","article-title":"The status of serum vitamin D in patients with active Behcet\u2019s disease compared with controls","volume":"17","author":"Khabbazi","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.imlet.2018.11.005_bib0030","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","article-title":"Close association of HLA-Bw51 with Behcet\u2019s disease","volume":"100","author":"Ohno","year":"1982","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.imlet.2018.11.005_bib0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2018.01.014","article-title":"The role of gut microbiota and IL-23\/IL-17 pathway in ankylosing spondylitis immunopathogenesis: new insights and updates","volume":"196","author":"Babaie","year":"2018","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.imlet.2018.11.005_bib0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/03009742.2014.945477","article-title":"Vitamin D receptor gene polymorphisms in Iranian Azary patients with Behcet\u2019s disease","volume":"44","author":"Kolahi","year":"2015","journal-title":"Scand. J. Rheumatol."},{"issue":"12","key":"10.1016\/j.imlet.2018.11.005_bib0045","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/art.37708","article-title":"Identification of a susceptibility locus in STAT4 for Behcet\u2019s disease in Han Chinese in a genome-wide association study","volume":"64","author":"Hou","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.imlet.2018.11.005_bib0050","first-page":"1897","article-title":"A single nucleotide polymorphism in the FOXP3 gene associated with behcet\u2019s disease in an iranian population","volume":"61","author":"Hosseini","year":"2015","journal-title":"Clin. Lab."},{"issue":"4 Suppl 67","key":"10.1016\/j.imlet.2018.11.005_bib0055","first-page":"S28","article-title":"Association of interleukin-2, interleukin-4 and transforming growth factor-beta gene polymorphisms with Behcet\u2019s disease","volume":"29","author":"Shahram","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2018.11.005_bib0060","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/ar4570","article-title":"Decreased interleukin 27 expression is associated with active uveitis in Behcet\u2019s disease","volume":"16","author":"Wang","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.imlet.2018.11.005_bib0065","first-page":"855","article-title":"IL-27 gene polymorphisms in iranian patients with behcet\u2019s disease","volume":"62","author":"Dehghanzadeh","year":"2016","journal-title":"Clin. Lab."},{"issue":"7","key":"10.1016\/j.imlet.2018.11.005_bib0070","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/ard.2009.119420","article-title":"IL-23R gene confers susceptibility to Behcet\u2019s disease in a Chinese Han population","volume":"69","author":"Jiang","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.imlet.2018.11.005_bib0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00296-009-1134-x","article-title":"TNF-alpha gene polymorphisms in Iranian Azeri Turkish patients with Behcet\u2019s disease","volume":"30","author":"Bonyadi","year":"2009","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.imlet.2018.11.005_bib0080","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clim.2008.06.006","article-title":"SUMO4 gene polymorphisms in Chinese Han patients with Behcet\u2019s disease","volume":"129","author":"Hou","year":"2008","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2018.11.005_bib0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/03009742.2011.562532","article-title":"Common MEFV mutations in Iranian Azeri Turkish patients with Behcet\u2019s disease","volume":"40","author":"Esmaeili","year":"2011","journal-title":"Scand. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.imlet.2018.11.005_bib0090","first-page":"103","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family, Nature reviews","volume":"10","author":"Liew","year":"2010","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.imlet.2018.11.005_bib0095","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S1471-4906(01)02040-3","article-title":"A new nomenclature for IL-1-family genes","volume":"22","author":"Sims","year":"2001","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2018.11.005_bib0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.humimm.2015.03.011","article-title":"Interleukin-33 and Behcet disease: another cytokine among others","volume":"76","author":"Hamzaoui","year":"2015","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2018.11.005_bib0105","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/17843286.2017.1314241","article-title":"Investigating the role of IL-33 in the pathogenesis of behcet\u2019s disease","volume":"72","author":"Cerci","year":"2017","journal-title":"Acta Clin. Belg."},{"issue":"8","key":"10.1016\/j.imlet.2018.11.005_bib0110","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3346\/jkms.2013.28.8.1145","article-title":"Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet\u2019s disease","volume":"28","author":"Kim","year":"2013","journal-title":"J. Korean Med. Sci."},{"issue":"5","key":"10.1016\/j.imlet.2018.11.005_bib0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.imlet.2018.11.005_bib0120","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jaci.2008.04.005","article-title":"A novel IL-1 family cytokine, IL-33, potently activates human eosinophils","volume":"121","author":"Cherry","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2018.11.005_bib0125","doi-asserted-by":"crossref","first-page":"e0143153","DOI":"10.1371\/journal.pone.0143153","article-title":"Protective role of the interleukin 33 rs3939286 gene polymorphism in the development of subclinical atherosclerosis in rheumatoid arthritis patients","volume":"10","author":"Lopez-Mejias","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.imlet.2018.11.005_bib0130","doi-asserted-by":"crossref","first-page":"e62144","DOI":"10.1371\/journal.pone.0062144","article-title":"Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease","volume":"8","author":"Latiano","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.imlet.2018.11.005_bib0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00296-014-3111-2","article-title":"Serum IL-33 level and IL-33 gene polymorphisms in Behcet\u2019s disease","volume":"35","author":"Koca","year":"2015","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.imlet.2018.11.005_bib0140","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/pai.12597","article-title":"P.S. group, IL-33 polymorphisms are associated with increased risk of hay fever and reduced regulatory T cells in a birth cohort","volume":"27","author":"Schroder","year":"2016","journal-title":"Pediatr. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2018.11.005_bib0145","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/ar4554","article-title":"Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis","volume":"16","author":"Li","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2018.11.005_bib0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cyto.2017.09.028","article-title":"IL-33 gene variants and protein expression in pediatric Tunisian asthmatic patients","volume":"104","author":"Charrad","year":"2018","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.imlet.2018.11.005_bib0155","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Behcet\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"D. International Team for the Revision of the International Criteria for Behcet\u2019s","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.imlet.2018.11.005_bib0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1756-185X.2009.01455.x","article-title":"Validation of the international criteria for behcet\u2019s disease (ICBD) in Iran","volume":"13","author":"Davatchi","year":"2010","journal-title":"Int. J. Rheum. Dis."},{"issue":"3 Suppl 77","key":"10.1016\/j.imlet.2018.11.005_bib0165","first-page":"6","article-title":"Serum IL-33 levels and skin mRNA expression in Behcet\u2019s disease","volume":"31","author":"Hamzaoui","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.imlet.2018.11.005_bib0170","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/cmi.2014.31","article-title":"Increased interleukin 33 in patients with neuro-Behcet\u2019s disease: correlation with MCP-1 and IP-10 chemokines","volume":"11","author":"Hamzaoui","year":"2014","journal-title":"Cell. Mol. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817304431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817304431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T12:42:40Z","timestamp":1562676160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817304431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":34,"alternative-id":["S0165247817304431"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2018.11.005","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-33 gene expression and rs1342326 polymorphism in Beh\u00e7et\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2018.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}